Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem care
Practical Neurology · 30.06.2026 · pn-2026-005241
DOI: 10.1136/pn-2026-005241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Practical Neurology, online erschienen am 30.06.2026. Verfasst von Wesley Reintjes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Oculopharyngeal muscular dystrophy (OPMD) is a rare, late-onset disorder caused by pathogenic expansions in the PABPN1 (poly(A)-binding protein nuclear 1) gene. It is characterised by progressive ptosis, dysphagia and proximal limb weakness. Due to the rarity of OPMD, patient care in general hospitals may be compromised by limited expertise, particularly during ocular, pharyngeal or gastrointestinal procedures. This can cause unnecessary complications which may be life-threatening. Here we provide a concise overview of the symptoms and signs, diagnostic investigations, counselling and symptomatic management of OPMD. We aim to contribute to the development of a tailored, multisystem approach to patient management across all care settings. We hope to improve awareness of OPMD and to improve healthcare for patients with this condition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of Rehabilitation, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of Medicine, Neurology, The Ottawa Hospital, Ottawa, Ontario, Canada.
- OPMD Association, San Antonio, Texas, USA.
- Functional Unit of Neuromuscular Pathology, Department of Neuropathology, Myology Institute, Pitié-Salpêtrière Hospital, Assistance Publique des Hôpitaux de Paris, Sorbonne University, Paris, France.
- John Walton Muscular Dystrophy Research Centre, Faculty of Medical Sciences, Newcastle University; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Zitieren
APA
Reintjes, W., Knuijt, S., Oelbrandt, F., Hastings, R. N., Evangelista, T., Tasca, G., Warman Chardon, J., & Voermans, N. (2026). Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem care. Practical Neurology, pn-2026-005241. https://doi.org/10.1136/pn-2026-005241
Vancouver
Reintjes W, Knuijt S, Oelbrandt F, Hastings RN, Evangelista T, Tasca G, et al. Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem care. Practical Neurology. 2026:pn-2026-005241. doi:10.1136/pn-2026-005241
BibTeX
@article{Reintjes2026,
author = {Reintjes, Wesley and Knuijt, Simone and Oelbrandt, Fien and Hastings, Rebecca N and Evangelista, Teresinha and Tasca, Giorgio and Warman Chardon, Jodi and Voermans, Nicol},
title = {Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem care},
journal = {Practical Neurology},
year = {2026},
pages = {pn--2026--005241},
doi = {10.1136/pn-2026-005241}
}
EUVIMED